目录产品 » ALK Antibody (4A4), mAb, Mouse

ALK (4A4), mAb, Mouse

Anaplastic lymphoma kinase (ALK) known as ALK tyrosine kinase receptor or CD246, is a tyrosine kinase receptor. ALK is an important biomarker for diagnosis of non-small cell lung cancer (NSCLC). Zykadia (Ceritinib) has been permitted for treating patent with ALK-Positive NSCLC.
V02101
询价

联系我们
Description

Anaplastic lymphoma kinase (ALK) known as ALK tyrosine kinase receptor or CD246, is a tyrosine kinase receptor. ALK is an important biomarker for diagnosis of non-small cell lung cancer (NSCLC). Zykadia (Ceritinib) has been permitted for treating patent with ALK-Positive NSCLC.

Synonyms

ALK Antibody (4A4), mAb, Mouse

Note

GenScript can customize this product per customer's request including product size, buffer components, etc.

Storage For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.

Target Background Anaplastic lymphoma kinase (ALK) known as ALK tyrosine kinase receptor or CD246, is a tyrosine kinase receptor. ALK is an important biomarker for diagnosis of non-small cell lung cancer (NSCLC). Zykadia (Ceritinib) has been permitted for treating patent with ALK-Positive NSCLC.

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*